Showing results (31-40 of 609) with videos related to
Sort By:
Pageof 61
Urologic Oncology|December 1, 2007
Open radical retropubic prostatectomyStacy Loeb, William J CatalonaTranslational Andrology and Urology|March 30, 2018
Biomarkers in active surveillanceStacy Loeb, Jeffrey J TosoianCancer Letters|January 30, 2007
Prostate-specific antigen in clinical practiceStacy Loeb, William J CatalonaCurrent Urology Reports|April 25, 2006
Management of the complications of external beam radiotherapy and brachytherapyStacy Loeb, Robert B NadlerJournal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Point: Impact of prostate-specific antigen velocity on management decisions and recommendationsStacy Loeb, H Ballentine CarterThe Journal of Urology|August 21, 2012
Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancerJeffrey J Tosoian, Stacy Loeb, Zhaoyong Feng, et al.Urology|August 10, 2010
Tumor grade at margins of resection in radical prostatectomy specimens is an independent predictor of prognosisFadi Brimo, Alan W Partin, Jonathan I EpsteinThe Journal of Urology|July 20, 2002
Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. rangeAlexander Haese, Robert T Dworschack, Alan W PartinReviews in Urology|April 25, 2009
Robotic image-guided needle interventions of the prostatePierre C Mozer, Alan W Partin, Dan StoianoviciEuropean Urology Oncology|January 4, 2021
Clinical Implications of Germline Testing in Newly Diagnosed Prostate CancerStacy Loeb, Veda N GiriPageof 61